Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
- Argus Research raised the price target for Accenture Plc (NYSE:ACN) from $220 to $260. Argus Research analyst Jim Kelleher maintained a Buy rating. Accenture shares closed at $212.30 on Thursday. See how other analysts view this stock.
- Susquehanna cut CSX Corp (NASDAQ:CSX) price target from $59 to $55. Susquehanna analyst Bascome Majors maintained a Positive rating. CSX shares closed at $46.54 on Thursday. See how other analysts view this stock.
- Rosenblatt raised price target for Synaptics Inc (NASDAQ:SYNA) from $115 to $123. Rosenblatt analyst Kevin Cassidy maintained a Neutral rating. Synaptics shares closed at $106.15 on Thursday. See how other analysts view this stock.
- Baird cut the price target for Nike Inc (NYSE:NKE) from $44 to $36. Baird analyst Jonathan Komp maintained a Neutral rating. Nike shares closed at $35.15 on Thursday. See how other analysts view this stock.
- Freedom Capital Markets raised AtriCure Inc (NASDAQ:ATRC) price target from $43 to $57. Freedom Capital Markets analyst Keith Hinton downgraded the stock from Buy to Hold. AtriCure shares closed at $53.59 on Thursday. See how other analysts view this stock.
- Stifel cut McCormick & Company Inc (NYSE:MKC) price target from $55 to $48. Stifel analyst Matthew Smith maintained a Hold rating. McCormick shares closed at $44.14 on Thursday. See how other analysts view this stock.
- HC Wainwright & Co. lowered Foghorn Therapeutics Inc (NASDAQ:FHTX) price target from $13 to $5. HC Wainwright & Co. analyst Andres Y. Maldonado maintained a Buy rating. Foghorn Therapeutics shares closed at $2.92 on Thursday. See how other analysts view this stock.
- B of A Securities raised the price target for Marathon Petroleum Corp (NYSE:MPC) from $410 to $426. B of A Securities analyst Doug Leggate maintained a Neutral rating. Marathon Petroleum shares closed at $420.15 on Thursday. See how other analysts view this stock.
- Needham increased Shattuck Labs Inc (NASDAQ:STTK) price target from $17 to $19. Needham analyst Joseph Stringer maintained a Buy rating. Shattuck Labs shares closed at $6.84 on Thursday. See how other analysts view this stock.
- Rothschild & Co raised Abbott Laboratories (NYSE:ABT) price target from $119 to $127. Rothschild & Co analyst Ed Ridley-Day upgraded the stock from Neutral to Buy. Abbott shares closed at $96.69 on Thursday. See how other analysts view this stock.
Considering buying ABT stock? Here’s what analysts think:
Photo via Shutterstock